+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

  • ID: 4772324
  • Report
  • 302 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Aegis Therapeutics LLC
  • Callitas Therapeutics Inc
  • Ghent University
  • Merck & Co Inc
  • Orphanse Healthcare SAS
  • Suda Pharmaceuticals Ltd
  • MORE
Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Transmucosal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transmucosal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transmucosal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aegis Therapeutics LLC
  • Callitas Therapeutics Inc
  • Ghent University
  • Merck & Co Inc
  • Orphanse Healthcare SAS
  • Suda Pharmaceuticals Ltd
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Transmucosal Drug Delivery Devices Overview

3 Products under Development
3.1 Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Transmucosal Drug Delivery Devices - Pipeline Products by Segment
3.3 Transmucosal Drug Delivery Devices - Pipeline Products by Territory
3.4 Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Transmucosal Drug Delivery Devices - Ongoing Clinical Trials

4 Transmucosal Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Transmucosal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development

5 Transmucosal Drug Delivery Devices Companies and Product Overview
5.1 AcelRx Pharmaceuticals Inc Company Overview
5.2 Aegis Therapeutics LLC Company Overview
5.3 AFYX Therapeutics A/S Company Overview
5.4 Albert Einstein College of Medicine Company Overview
5.5 Allergan Plc Company Overview
5.6 Amphastar Pharmaceuticals Inc Company Overview
5.7 Aquestive Therapeutics Inc Company Overview
5.8 ARS Pharmaceuticals Inc Company Overview
5.9 Auritec Pharmaceuticals Inc Company Overview
5.10 BeFree! Company Overview
5.11 Bespak Europe Ltd Company Overview
5.12 Biorings LLC Company Overview
5.13 BioXcel Therapeutics Inc Company Overview
5.14 Callitas Therapeutics Inc Company Overview
5.15 Columbia University Company Overview
5.16 Combinent BioMedical Systems Inc Company Overview
5.17 Conrad Company Overview
5.18 Dare Bioscience Inc Company Overview
5.19 Emergent BioSolutions Inc Company Overview
5.20 Evestra Inc Company Overview
5.21 Evofem Biosciences Inc Company Overview
5.22 Evoke Pharma Inc Company Overview
5.23 EyeGate Pharmaceuticals Inc Company Overview
5.24 Ferring Pharmaceuticals AS Company Overview
5.25 Ghent University Company Overview
5.26 Glenmark Pharmaceuticals Ltd Company Overview
5.27 Hebrew University of Jerusalem Company Overview
5.28 INSYS Therapeutics Inc Company Overview
5.29 IntelGenx Corp Company Overview
5.30 Janssen Research & Development LLC Company Overview
5.31 Karessa Pharma AB Company Overview
5.32 Kytogenics Pharmaceuticals Inc Company Overview
5.33 Laboratoire HRA Pharma SAS Company Overview
5.34 Laboratorios Andromaco Company Overview
5.35 Lyra Therapeutics Company Overview
5.36 McNeil AB Company Overview
5.37 Medlab Clinical Ltd Company Overview
5.38 Merck & Co Inc Company Overview
5.39 Merck Serono SA Company Overview
5.40 Merck Sharp & Dohme Ltd Company Overview
5.41 Mithra Pharmaceuticals SA Company Overview
5.42 Mystic Pharmaceuticals Inc Company Overview
5.43 Nanosys Inc Company Overview
5.44 NorInvent AB Company Overview
5.45 Novus Therapeutics Inc Company Overview
5.46 Oak Crest Institute of Science Company Overview
5.47 Opiant Pharmaceuticals Inc Company Overview
5.48 OptiNose AS Company Overview
5.49 Orion Biotechnology Canada Ltd Company Overview
5.50 Orphanse Healthcare SAS Company Overview
5.51 Palette Life Sciences AB Company Overview
5.52 Phoenix Life Sciences International Ltd Company Overview
5.53 Privo Technologies LLC Company Overview
5.54 Promius Pharma LLC Company Overview
5.55 RDD Pharma Ltd Company Overview
5.56 Renown Pharma Ltd Company Overview
5.57 Rhinomed Ltd Company Overview
5.58 Scientus Pharma Inc Company Overview
5.59 Shenox Pharmaceuticals LLC Company Overview
5.60 Shin Nippon Biomedical Laboratories Ltd Company Overview
5.61 Suda Pharmaceuticals Ltd Company Overview
5.62 Texas Tech University Company Overview
5.63 The Hong Kong University of Science and Technology Company Overview
5.64 Therakind Ltd Company Overview
5.65 TherapeuticsMD Inc Company Overview
5.66 Tiziana Life Sciences PLC Company Overview
5.67 UCB SA Company Overview
5.68 University of North Carolina at Chapel Hill Company Overview
5.69 University of Pittsburgh Company Overview
5.70 University of South Florida Company Overview
5.71 University of Texas at Austin Company Overview
5.72 University of the Witwatersrand Company Overview
5.73 University of Washington Company Overview
5.74 Washington University in St Louis Company Overview

6 Transmucosal Drug Delivery Devices - Recent Developments
6.1 Apr 30, 2019: Aptar reports first quarter results
6.2 Apr 30, 2019: In 2018, Marinomed set the course for accelerated growth
6.3 Apr 08, 2019: Opiant Pharmaceuticals announces publication of clinical pharmacokinetic data supporting potential of OPNT003, nasal nalmefene, for treatment of synthetic opioid overdose
6.4 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors
6.5 Apr 04, 2019: IntelGenx Presents at 14th International Conference on Alzheimer's and Parkinson's Disease
6.6 Mar 29, 2019: World-renowned scientist, described as the edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Dare Bioscience scientific advisory board
6.7 Mar 25, 2019: INSYS Therapeutics to present poster of pharmacokinetic study of Naloxone novel nasal spray at The College on Problems of Drug Dependence Annual Scientific Meeting
6.8 Mar 25, 2019: TherapeuticsMD announces oral and poster presentations on ANNOVERA at the Endocrine Society 2019 Annual Meeting
6.9 Mar 21, 2019: Aptar Pharma to showcase new market innovations at Interphex 2019, New York City
6.10 Mar 20, 2019: Superior Psychiatric Services announces new services and products for Depression treatment

7 Appendix
7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer

List of Tables
  • Table 1: Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
  • Table 2: Transmucosal Drug Delivery Devices - Pipeline Products by Segment
  • Table 3: Transmucosal Drug Delivery Devices - Pipeline Products by Territory
  • Table 4: Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Table 5: Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Transmucosal Drug Delivery Devices - Ongoing Clinical Trials
  • Table 7: Transmucosal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
  • Table 9: AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: ARX-02 Sufentanil NanoTab BTP Management System - Product Status
  • Table 11: ARX-02 Sufentanil NanoTab BTP Management System - Product Description
  • Table 12: ARX-03 Sufentanil/Trazolam NanoTab - Product Status
  • Table 13: ARX-03 Sufentanil/Trazolam NanoTab - Product Description
  • Table 14: ZALVISO - Product Status
  • Table 15: ZALVISO - Product Description
  • Table 16: AcelRx Pharmaceuticals Inc - Ongoing Clinical Trials Overview
  • Table 17: ZALVISO - Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections
  • Table 18: ZALVISO - Usability and Satisfaction Evaluation of Sufentanil Sublingual Patient-controlled Analgesia after Elective Surgery with Moderate-to-severe Postoperative Pain
  • Table 19: Aegis Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: VALTOCO Nasal Spray - Product Status
  • Table 21: VALTOCO Nasal Spray - Product Description
  • Table 22: Aegis Therapeutics LLC - Ongoing Clinical Trials Overview
  • Table 23: VALTOCO Nasal Spray - A 12-month Open-label, Repeat-dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)
  • Table 24: VALTOCO Nasal Spray - An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
  • Table 25: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Rivelin Combo Patch - Product Status
  • Table 27: Rivelin Combo Patch - Product Description
  • Table 28: AFYX Therapeutics A/S - Ongoing Clinical Trials Overview
  • Table 29: Rivelin Combo Patch - A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate When Administered Intra-orally Twice Daily in Patients with Oral Lichen Planus (OLP) Using Rivelin-CLO Patches
  • Table 30: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Drug-Impregnated Intravaginal Ring - Product Status
  • Table 32: Drug-Impregnated Intravaginal Ring - Product Description
  • Table 33: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Vaginal Ring Contraceptive - Product Status
  • Table 35: Vaginal Ring Contraceptive - Product Description
  • Table 36: Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Intranasal Naloxone Spray - Product Status
  • Table 38: Intranasal Naloxone Spray - Product Description
  • Table 39: Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: APL-130277 Sublingual Soluble Film - Product Status
  • Table 41: APL-130277 Sublingual Soluble Film - Product Description
  • Table 42: AQST-108 Sublingual Soluble Film - Product Status
  • Table 43: AQST-108 Sublingual Soluble Film - Product Description
  • Table 44: AQST-119 Oral Soluble Film - Product Status
  • Table 45: AQST-119 Oral Soluble Film - Product Description
  • Table 46: AQST-305 Buccal Soluble Film - Product Status
  • Table 47: AQST-305 Buccal Soluble Film - Product Description
  • Table 48: Diazepam (Libervant) Buccal Film - Product Status
  • Table 49: Diazepam (Libervant) Buccal Film - Product Description
  • Table 50: Exservan - Product Status
  • Table 51: Exservan - Product Description
  • Table 52: Aquestive Therapeutics Inc - Ongoing Clinical Trials Overview
  • Table 53: Diazepam (Libervant) Buccal Film - A Multicenter, Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects with Epilepsy
  • Table 54: ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: ARS-1 - Product Status
  • Table 56: ARS-1 - Product Description
  • Table 57: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Versa Intravaginal Ring - Acromegaly - Product Status
  • Table 59: Versa Intravaginal Ring - Acromegaly - Product Description
  • Table 60: Versa Intravaginal Ring - Alzheimer's Disease - Product Status
List of Figures
  • Figure 1: Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
  • Figure 2: Transmucosal Drug Delivery Devices - Pipeline Products by Segment
  • Figure 3: Transmucosal Drug Delivery Devices - Pipeline Products by Territory
  • Figure 4: Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Figure 5: Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Transmucosal Drug Delivery Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AcelRx Pharmaceuticals Inc
  • Aegis Therapeutics LLC
  • AFYX Therapeutics A/S
  • Albert Einstein College of Medicine
  • Allergan Plc
  • Amphastar Pharmaceuticals Inc
  • Aquestive Therapeutics Inc
  • ARS Pharmaceuticals Inc
  • Auritec Pharmaceuticals Inc
  • BeFree!
  • Bespak Europe Ltd
  • Biorings LLC
  • BioXcel Therapeutics Inc
  • Callitas Therapeutics Inc
  • Columbia University
  • Combinent BioMedical Systems Inc
  • Conrad
  • Dare Bioscience Inc
  • Emergent BioSolutions Inc
  • Evestra Inc
  • Evofem Biosciences Inc
  • Evoke Pharma Inc
  • EyeGate Pharmaceuticals Inc
  • Ferring Pharmaceuticals AS
  • Ghent University
  • Glenmark Pharmaceuticals Ltd
  • Hebrew University of Jerusalem
  • INSYS Therapeutics Inc
  • IntelGenx Corp
  • Janssen Research & Development LLC
  • Karessa Pharma AB
  • Kytogenics Pharmaceuticals Inc
  • Laboratoire HRA Pharma SAS
  • Laboratorios Andromaco
  • Lyra Therapeutics
  • McNeil AB
  • Medlab Clinical Ltd
  • Merck & Co Inc
  • Merck Serono SA
  • Merck Sharp & Dohme Ltd
  • Mithra Pharmaceuticals SA
  • Mystic Pharmaceuticals Inc
  • Nanosys Inc
  • NorInvent AB
  • Novus Therapeutics Inc
  • Oak Crest Institute of Science
  • Opiant Pharmaceuticals Inc
  • OptiNose AS
  • Orion Biotechnology Canada Ltd
  • Orphanse Healthcare SAS
  • Palette Life Sciences AB
  • Phoenix Life Sciences International Ltd
  • Privo Technologies LLC
  • Promius Pharma LLC
  • RDD Pharma Ltd
  • Renown Pharma Ltd
  • Rhinomed Ltd
  • Scientus Pharma Inc
  • Shenox Pharmaceuticals LLC
  • Shin Nippon Biomedical Laboratories Ltd
  • Suda Pharmaceuticals Ltd
  • Texas Tech University
  • The Hong Kong University of Science and Technology
  • Therakind Ltd
  • TherapeuticsMD Inc
  • Tiziana Life Sciences PLC
  • UCB SA
  • University of North Carolina at Chapel Hill
  • University of Pittsburgh
  • University of South Florida
  • University of Texas at Austin
  • University of the Witwatersrand
  • University of Washington
  • Washington University in St Louis
Note: Product cover images may vary from those shown
Adroll
adroll